Study Design. A cross-sectional analysis.
D
uchenne muscular dystrophy (DMD) is an Xlinked recessive disorder caused by a mutation in the DMD gene, typically a deletion, found at locus Xp21.2.
1 Affected myocytes lack dystrophin resulting in a weakened cell membrane and premature cell death. 2 DMD is believed to occur in 1 in 3500 live male births and affects 1.7 to 4.7 males per million worldwide. [3] [4] [5] [6] Between 75% and 90% of patients with DMD develop significant scoliosis as a result of trunk muscle weakness. [7] [8] [9] [10] [11] Traditionally, scoliosis surgery is performed early in the disease process before significant pulmonary compromise develops.
It has been suggested that glucocorticoid treatment slows the functional decline of DMD patients, prolonging ambulation and possibly decreasing the risk of progressive spinal deformity through a variety of mechanisms. 8, 9, 26 In 2004, Alman et al., 9 in a comparative study, reported that glucocorticoid treatment decreased the progression of scoliosis in patients with DMD as compared with the controls. In 2013, Lebel et al. 8 reported the 15-year follow-up on these same patients demonstrating persistently decreased progression of scoliosis in the treatment group. Our objective was to identify the impact of the comparative study by Alman et al. 9 on the national surgical treatment of scoliosis in DMD. Our hypothesis was that rates of scoliosis surgery for DMD will be decreased following the publication of the comparative study.
MATERIALS AND METHODS

Data Source and Design
We used Healthcare Cost and Utilization Project's (HCUP) Nationwide Inpatient Sample (NIS) databases from 2001 to 2012 to address the research questions. NIS databases are the largest national all-payer inpatient databases, and contain data about inpatient stays, such as demographics, diagnoses, and procedures based on the ICD-9-CM codes, and hospital characteristics that are obtained from billing records. For each year from 2001 to 2011, a 20% sample of US community hospitals participating in HCUP was generated through a single-stage stratified sampling approach, and all discharges from these hospitals were included in the NIS database. In 2012, this sampling strategy was redesigned to include a sample of discharges from all hospitals participating in HCUP. 31 Revised discharge weights were developed by HCUP to generate nationally representative trend estimates while accounting for the change in the sampling design in 2012. 32 The 2011 database contains variables for approximately 8 million stays from 1049 hospitals in 46 states, whereas the 2012 database contains variables for approximately 7 million stays from 4378 hospitals in 44 states. 31 Elaborate quality control procedures are used to ensure the validity and consistency of the databases.
Study Cohort
We used the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) to identify male inpatient stays with a principal or secondary diagnosis of DMD (diagnosis codes 359.0 and 359.1) who were surgically managed using one of the following three spinal fusion approaches: (1) anterior approach only (procedure codes 81.04 and/or 81.06); (2) posterior approach only (procedure codes 81.05 and/or 81.07), and (3) combined anterior and posterior approach. The final cohort comprised 396 inpatient stays, which when weighted using NIS discharge weights resulted in a nationally representative cohort of 1874 stays for DMD from 2001 to 2012. 31 
Outcomes
The primary outcome of interest was the national trend in spine fusion for DMD before and after the publication of the comparative study on glucocorticoids for scoliosis in DMD. We examined the distribution of patient and hospital characteristics among cohorts of posterior fusion from 2001 to 2004 (period 1; before publication of the comparative study), 2005 to 2008 (period 2; immediately following publication of the comparative study), and 2009 to 2012 (period 3; moderate duration following publication of the comparative study). We computed annual rates (surgeries per million US males per year) of the surgical approaches by dividing the number of surgeries with the US Census Bureau estimates of the US male population for the particular year. 33 Additionally for patients undergoing only posterior approach surgeries, we examined patient and hospital factors that predicted (1) risk of postoperative complications, (2) discharge disposition, (3) length of stay (LOS), and (4) cost of inpatient stays.
We identified postoperative complications using secondary ICD-9-CM diagnostic codes and diagnostic related group (DRGs). We constructed a binary indicator for the presence or absence of at least one postoperative complication identified before discharge from the hospital. The complications considered include cardiac, neurological, gastrointestinal, pulmonary, renal, and wound complications, venous thromboembolism, and incidental durotomies. The discharge disposition variable was a binary variable indicating either a routine discharge to home or a nonroutine discharge (all other discharges). Hospital LOS is the difference between admission and discharge date. We derived inpatient costs using inpatient stay charges (excluding professional fees and noncovered charges) and the hospital-specific all-payer inpatient cost to charge ratios. We accounted for inflation over time by adjusting costs to 2012 dollars by using the Consumer Price Index. 34 
Independent Variables and Covariates
To examine trends in annual rates of spinal fusion and surgical approaches, the independent variable of interest was the year of surgery. In the multivariate analyses for identifying significant predictors of outcomes for posterior surgery patients, we controlled for patient-and hospitallevel covariates. Patient age was coded as a binary variable using the median age of the cohort-with 1 indicating age greater than 14 years and 0 indicating age less than or equal to 14 years. Race data-points were missing for approximately 22% of the cohort, so race was categorized race into White, Nonwhite, and Missing categories. Primary payer variable was Medicaid, private insurance, and other (including Medicare, self-pay, no charge, and other) categories. We used the Elixhauser AHRQ ICD-9-CM coding algorithm to account for 29 pre-operative comorbidities. 35 We accounted for the temporal trend in outcomes by including the year of surgery in the multivariate models. For discharge disposition and cost of hospital stay outcomes, we included a binary variable to indicate the identification of at least one 
Statistical Analyses
We used adjusted Wald tests to identify significant differences in the distribution of patient and hospital characteristics between the three time periods. For the multivariate pooled cross-sectional analyses, we used logistic regressions (for complication and discharge disposition outcomes), and linear regressions (for LOS and inpatient costs) to identify significant patient-and hospital-level predictors. In the linear regression models, we exponentiated the log-transformed estimates to derive a measure of percentage difference. All analyses were weighted using HCUP's trend weights to account for the sampling design. We used AHRQ's HCUPnet, which is an online query tool, to check for the accuracy of our national weighted estimates for diagnoses and procedures. We used goodness-of-fit tests to check for calibration, and the C-statistic to examine the discrimination of the logistic regression models. We examined the residuals of linear regression models to confirm that model assumptions were met. Variance inflation factor was used to rule out multicollinearity. Statistical analyses were performed using the survey commands in Stata 13 for Windows (Stata Corp., College Station, TX). Statistical tests were two-sided and P < 0.05 was used to indicate statistical significance.
RESULTS National Trends: 2001 to 2012
The weighted study cohort was composed of 1874 male inpatient stays with a diagnosis of DMD that were surgically managed from 2001 to 2012. During this period, the overall rate of DMD surgeries declined by 48%-from 1.87 surgeries in 2001 to 0.97 surgeries in 2012 per million US males per year ( Table 1) . As posterior surgeries accounted for an average of 98% of all fusion surgeries performed annually, the decline in posterior surgeries was commensurate with the overall decline-a 46% decline from 1.80 surgeries in 2001 to 0.97 surgeries in 2012 per million US males per year. This decline was significantly pronounced following the publication of the comparative study [periods 2 and 3; For period 2 vs. period 1: incidence rate ratio (IRR) ¼ 0.71, 95% confidence interval (95% CI) ¼ 0.56-0.91, P ¼ 0.01; For period 3 vs. period 1: Figure 1A) .
In 2001, posterior-only surgeries accounted for 96% of all fusion surgeries performed for DMD, whereas anterioronly and combined surgeries accounted for 2% each. In 2012, posterior-only surgeries accounted for all fusion surgeries performed for DMD ( Figure 1B ). 
Characteristics of Study Subjects
Unadjusted Outcomes
In period 3, the complication rate among posterior-only surgeries was 35.41% (95% CI ¼ 25.31-45.52) (Table 3 
Adjusted Outcomes
After controlling for relevant covariates ( 
DISCUSSION
As demonstrated in several studies, the therapeutic effects of glucocorticoids in DMD are numerous. These include an increase in muscle strength, prolonged time until loss of ambulation, stabilization of forced vital capacity, and a general improvement in health and quality of life in the short term. 19, 20 Steroids appear to slow progression of scoliosis even after patients become wheel-chair dependent and are now widely accepted as a treatment for the prevention of scoliosis progression in DMD. 8, 9, 19, 20, 26 Complications with prolonged glucocorticoid use are numerous and include osteoporosis, compression fractures, cataracts, avascular necrosis, decreased longitudinal growth, increased body weight, lower limb fractures, and a delay in puberty. 36, 37 Although not yet approved by the Food and Drug Administration, deflazacort is an oxazolone derivative of prednisone that has been used for DMD in Canada and Europe. There are currently no prospective studies on the efficacy of prednisone versus deflazacort, and adverse side effects occur in both treatment groups. 24, [38] [39] [40] The use of NIS data to demonstrate the impact of a landmark publication on surgery practice patterns for metastatic disease of the spine has been previously reported. 41 The impact of this comparative study on the US national rates of spinal fusion for DMD was previously not known. Our study demonstrates that the national rates of fusion Adjusted to 2012 dollars using the Consumer Price Index to account for inflation. Ã P-value for test of differences in distribution of characteristic across the 3 time periods.
y Total cases.
z Confidence interval. § Derived from hospitalization charges using the cost-to-charge ratios for each year.
surgery did decrease 48% over the study period, with the largest decrease after the widespread adoption of glucocorticoid treatment. The comparative study reported by Alman et al. 9 in 2004 demonstrated a significant reduction in the development of scoliosis greater than 208 in patients treated with steroids as compared with a control group. The nonrandomized-controlled trial involving 54 boys began in 1993 and utilized deflazacort. An analysis of physical function while not utilizing assistance or assistive devices was performed. This included walking outdoors, walking 10 m, walking up a flight of stairs in less than 15 seconds, and getting up from the floor. 9 As previously reported by Biggar et al. 42 on this same treatment group of patients, independent walking, stair climbing, manual muscle strength, and pulmonary function were significantly better in the treatment group than the control group. Scoliosis greater than or equal to 208 developed in 76% of the control group patients by the conclusion of the study by Alman et al. 9 A 15-year follow-up on this population by Lebel et al. 8 demonstrated a 78% probability of avoiding spinal fusion surgery in the glucocorticoid group, and only an 8.3% probability of avoiding surgery in the control group. For complications and discharge disposition models, odds ratios of logistic regression models are presented. For length of stay and charges models, beta estimates of linear regressions for log transformed outcome variables are presented. Numbers in parentheses. Ã P < 0.05. ÃÃ P < 0.01.
posterior surgeries as seen in the 2012 data may be related to studies demonstrating a decrease in pulmonary function after anterior surgery in scoliosis surgery. [43] [44] [45] [46] [47] Another theory for this decrease in anterior surgery may reflect the ability of spinal implants to control scoliosis through posterior approaches. This pattern toward posterior fusion surgery has been demonstrated in other spinal conditions. [48] [49] [50] [51] [52] The average cost of inpatient stays significantly increased over the study period from $46,488 in period 1 to $82,995 in period 3 (P ¼ 0.001). This increase in the cost of spine fusion surgery and hospitalization has been seen in the treatment of other spinal conditions. 51, 53 Some of the increase may reflect the management of increasingly complex patients; however, a portion may also reflect increased costs for spinal implants.
During the study period, the inpatient complication rate ranged from 30% in period 1 to 35% in period 3, with pulmonary complications being the most common. It is difficult to determine the reasons for this increase in complications. Our hypothesis is that the patients who required surgery had likely failed glucocorticoid treatment for the prevention of their spinal deformity. These patients potentially had more severe disease burden with more comorbidities, increasing their chances of complications following surgery. Comorbidities were high in surgically treated patients, with weight loss, paralysis, congestive heart failure, coagulopathy, and electrolyte disorders being the most common. Although challenging in this patient population, these data suggest that every attempt should be made to correct all comorbidities before surgery. This is especially true for electrolyte disorders and iron-deficiency anemia.
There are several limitations to this study. Our study depends on the analysis of an administrative dataset that is limited by data entry quality. There may be temporal or regional differences in the interpretation of certain definitions or categories, or the use of ICD-9 codes. These differences may influence conclusions and therefore are significant limitations to this study. Also, NIS data do not provide any insight into long-term outcomes or any patientreported outcome information. Complications and readmission data are also not included and could change the interpretation of regional complications. Despite these limits, the advantages of NIS data are the ability to capture trends and changes in surgical patterns. Hospital charges can be evaluated on a national level in comparison to medical databases such as the American College of Surgeons National Surgical Quality Improvement Program (NSQIP).
CONCLUSION
In this first study evaluating national trends in scoliosis surgery for DMD, we found a significant decrease in the rate of surgery from 2001 to 2012. This decrease in surgery began in 2005 and continues through 2012, corresponding with the timeframe of widespread adoption of glucocorticoid therapy to prevent the progression of scoliosis in patients with DMD. This decrease is consistent with the publication of Alman et al. 9 and Lebel et al. 8 comparative studies using the glucocorticoid deflazacort for the prevention of scoliosis progression in DMD. This study utilizing the Nationwide Inpatient Sample demonstrated a similar decrease in scoliosis surgery. Our study demonstrates the practice changing impact landmark papers can have in orthopedic surgery.
Key Points
In evaluating national trends in scoliosis surgery for DMD, we found a significant decrease in the 
